Cargando…

Intein mediated high throughput screening for bispecific antibodies

Bispecific antibodies comprise extremely diverse architectures enabling complex modes of action, such as effector cell recruitment or conditional target modulation via dual targeting, not conveyed by monospecific antibodies. In recent years, research on bispecific therapeutics has substantially grow...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofmann, Tim, Schmidt, Johannes, Ciesielski, Elke, Becker, Stefan, Rysiok, Thomas, Schütte, Mark, Toleikis, Lars, Kolmar, Harald, Doerner, Achim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153837/
https://www.ncbi.nlm.nih.gov/pubmed/32151188
http://dx.doi.org/10.1080/19420862.2020.1731938
_version_ 1783521717320155136
author Hofmann, Tim
Schmidt, Johannes
Ciesielski, Elke
Becker, Stefan
Rysiok, Thomas
Schütte, Mark
Toleikis, Lars
Kolmar, Harald
Doerner, Achim
author_facet Hofmann, Tim
Schmidt, Johannes
Ciesielski, Elke
Becker, Stefan
Rysiok, Thomas
Schütte, Mark
Toleikis, Lars
Kolmar, Harald
Doerner, Achim
author_sort Hofmann, Tim
collection PubMed
description Bispecific antibodies comprise extremely diverse architectures enabling complex modes of action, such as effector cell recruitment or conditional target modulation via dual targeting, not conveyed by monospecific antibodies. In recent years, research on bispecific therapeutics has substantially grown. However, evaluation of binding moiety combinations often leads to undesired prolonged development times. While high throughput screening for small molecules and classical antibodies has evolved into a mature discipline in the pharmaceutical industry, dual-targeting antibody screening methodologies lack the ability to fully evaluate the tremendous number of possible combinations and cover only a limited portion of the combinatorial screening space. Here, we propose a novel combinatorial screening approach for bispecific IgG-like antibodies to extenuate screening limitations in industrial scale, expanding the limiting screening space. Harnessing the ability of a protein trans-splicing reaction by the split intein Npu DnaE, antibody fragments were reconstituted within the hinge region in vitro. This method allows for fully automated, rapid one-pot antibody reconstitution, providing biological activity in several biochemical and functional assays. The technology presented here is suitable for automated functional and combinatorial high throughput screening of bispecific antibodies.
format Online
Article
Text
id pubmed-7153837
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-71538372020-04-20 Intein mediated high throughput screening for bispecific antibodies Hofmann, Tim Schmidt, Johannes Ciesielski, Elke Becker, Stefan Rysiok, Thomas Schütte, Mark Toleikis, Lars Kolmar, Harald Doerner, Achim MAbs Report Bispecific antibodies comprise extremely diverse architectures enabling complex modes of action, such as effector cell recruitment or conditional target modulation via dual targeting, not conveyed by monospecific antibodies. In recent years, research on bispecific therapeutics has substantially grown. However, evaluation of binding moiety combinations often leads to undesired prolonged development times. While high throughput screening for small molecules and classical antibodies has evolved into a mature discipline in the pharmaceutical industry, dual-targeting antibody screening methodologies lack the ability to fully evaluate the tremendous number of possible combinations and cover only a limited portion of the combinatorial screening space. Here, we propose a novel combinatorial screening approach for bispecific IgG-like antibodies to extenuate screening limitations in industrial scale, expanding the limiting screening space. Harnessing the ability of a protein trans-splicing reaction by the split intein Npu DnaE, antibody fragments were reconstituted within the hinge region in vitro. This method allows for fully automated, rapid one-pot antibody reconstitution, providing biological activity in several biochemical and functional assays. The technology presented here is suitable for automated functional and combinatorial high throughput screening of bispecific antibodies. Taylor & Francis 2020-03-09 /pmc/articles/PMC7153837/ /pubmed/32151188 http://dx.doi.org/10.1080/19420862.2020.1731938 Text en © 2020 Merck Healthcare KGaA. Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Report
Hofmann, Tim
Schmidt, Johannes
Ciesielski, Elke
Becker, Stefan
Rysiok, Thomas
Schütte, Mark
Toleikis, Lars
Kolmar, Harald
Doerner, Achim
Intein mediated high throughput screening for bispecific antibodies
title Intein mediated high throughput screening for bispecific antibodies
title_full Intein mediated high throughput screening for bispecific antibodies
title_fullStr Intein mediated high throughput screening for bispecific antibodies
title_full_unstemmed Intein mediated high throughput screening for bispecific antibodies
title_short Intein mediated high throughput screening for bispecific antibodies
title_sort intein mediated high throughput screening for bispecific antibodies
topic Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153837/
https://www.ncbi.nlm.nih.gov/pubmed/32151188
http://dx.doi.org/10.1080/19420862.2020.1731938
work_keys_str_mv AT hofmanntim inteinmediatedhighthroughputscreeningforbispecificantibodies
AT schmidtjohannes inteinmediatedhighthroughputscreeningforbispecificantibodies
AT ciesielskielke inteinmediatedhighthroughputscreeningforbispecificantibodies
AT beckerstefan inteinmediatedhighthroughputscreeningforbispecificantibodies
AT rysiokthomas inteinmediatedhighthroughputscreeningforbispecificantibodies
AT schuttemark inteinmediatedhighthroughputscreeningforbispecificantibodies
AT toleikislars inteinmediatedhighthroughputscreeningforbispecificantibodies
AT kolmarharald inteinmediatedhighthroughputscreeningforbispecificantibodies
AT doernerachim inteinmediatedhighthroughputscreeningforbispecificantibodies